American International Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-694
| Closed | -$68K | – | 3258 |
|
|
2022
Q1 | $68K | Sell |
694
-49
| -7% | -$6.29K | ﹤0.01% | 2737 |
|
|
2021
Q4 | $121K | Sell |
743
-22
| -3% | -$4.83K | ﹤0.01% | 2634 |
|
|
2021
Q3 | $209K | Sell |
765
-18
| -2% | -$5.5K | ﹤0.01% | 2409 |
|
|
2021
Q2 | $310 | Sell |
783
-45
| -5% | -$21K | ﹤0.01% | 2237 |
|
|
2021
Q1 | $447 | Buy |
828
+2
| +0.2% | +$1.25K | ﹤0.01% | 1895 |
|
|
2020
Q4 | $312 | Sell |
826
-24
| -3% | -$9.54K | ﹤0.01% | 2031 |
|
|
2020
Q3 | $321K | Sell |
850
-19
| -2% | -$8.39K | ﹤0.01% | 1835 |
|
|
2020
Q2 | $428K | Buy |
869
+138
| +19% | +$61.5K | ﹤0.01% | 1679 |
|
|
2020
Q1 | $269K | Buy |
731
+61
| +9% | +$31.6K | ﹤0.01% | 1743 |
|
|
2019
Q4 | $474K | Sell |
670
-6
| -0.9% | -$4.13K | ﹤0.01% | 1721 |
|
|
2019
Q3 | $434K | Sell |
676
-4
| -0.6% | -$3.17K | ﹤0.01% | 1745 |
|
|
2019
Q2 | $595K | Buy |
680
+121
| +22% | +$83.2K | ﹤0.01% | 1604 |
|
|
2019
Q1 | $323K | Sell |
559
-18
| -3% | -$7.53K | ﹤0.01% | 1948 |
|
|
2018
Q4 | $162K | Sell |
577
-5
| -0.9% | -$1.98K | ﹤0.01% | 2304 |
|
|
2018
Q3 | $279K | Buy |
582
+11
| +2% | +$4.72K | ﹤0.01% | 2225 |
|
|
2018
Q2 | $259K | Buy |
571
+11
| +2% | +$6.97K | ﹤0.01% | 2217 |
|
|
2018
Q1 | $329K | Sell |
560
-30
| -5% | -$18.7K | ﹤0.01% | 1965 |
|
|
2017
Q4 | $366K | Buy |
590
+3
| +0.5% | +$2.15K | ﹤0.01% | 1970 |
|
|
2017
Q3 | $541K | Buy |
587
+44
| +8% | +$39.1K | ﹤0.01% | 1719 |
|
|
2017
Q2 | $507K | Buy |
543
+44
| +9% | +$43.1K | ﹤0.01% | 1697 |
|
|
2017
Q1 | $475K | Buy |
499
+33
| +7% | +$30.7K | ﹤0.01% | 1634 |
|
|
2016
Q4 | $374K | Sell |
466
-1
| -0.2% | -$901 | ﹤0.01% | 1820 |
|
|
2016
Q3 | $395K | Buy |
467
+1
| +0.2% | +$804 | ﹤0.01% | 1751 |
|
|
2016
Q2 | $384K | Sell |
466
-108
| -19% | -$118K | ﹤0.01% | 1743 |
|
|
2016
Q1 | $638K | Hold |
574
| – | – | ﹤0.01% | 1817 |
|
|
2015
Q4 | $715K | Sell |
574
-75
| -12% | -$124K | ﹤0.01% | 1736 |
|
|
2015
Q3 | $878K | Buy |
649
+85
| +15% | +$140K | ﹤0.01% | 1557 |
|
|
2015
Q2 | $1.01M | Buy |
564
+96
| +21% | +$149K | ﹤0.01% | 1570 |
|
|
2015
Q1 | $756K | Sell |
468
-6
| -1% | -$8.89K | ﹤0.01% | 1831 |
|
|
2014
Q4 | $360K | Sell |
474
-13
| -3% | -$6.9K | ﹤0.01% | 2416 |
|
|
2014
Q3 | $193K | Hold |
487
| – | – | ﹤0.01% | 2986 |
|
|
2014
Q2 | $295K | Sell |
487
-11
| -2% | -$6.13K | ﹤0.01% | 2642 |
|
|
2014
Q1 | $342K | Buy |
498
+9
| +2% | +$6.03K | ﹤0.01% | 2375 |
|
|
2013
Q4 | $318K | Buy |
489
+72
| +17% | +$42.9K | ﹤0.01% | 2370 |
|
|
2013
Q3 | $247K | Sell |
417
-5
| -1% | -$2.25K | ﹤0.01% | 2541 |
|
|
2013
Q2 | $133K | Buy |
+422
| New | +$117K | ﹤0.01% | 2908 |
|
Other funds holding TCRT
MP
DCM
LCM
American International Group's TCRT Position: Q2 2022 in Review
American International Group sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 694 shares — an estimated $68K sold.
American International Group first reported a position in TCRT in Q2 2013 and held it in 36 quarters. The position peaked at $1.01M in Q2 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.
- American International Group reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
- American International Group sold 694 Alaunos Therapeutics shares in Q2 2022, an estimated $68K.
- American International Group first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 36 quarters.
- American International Group's Alaunos Therapeutics position peaked at $1.01M in Q2 2015.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.
Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.